Literature DB >> 12594106

International variation in hip replacement rates.

H Merx1, K Dreinhöfer, P Schräder, T Stürmer, W Puhl, K-P Günther, H Brenner.   

Abstract

OBJECTIVES: To summarise epidemiological data on the frequency of hip replacements in the countries of the developed world, especially in countries of the Organisation for Economic Cooperation and Development (OECD), and to investigate whether missing consensus criteria for the indication for total hip replacement (THR) result in different replacement rates.
METHODS: Country-specific hip replacement rates were collected using the available literature, different data sources of national authorities, and estimates of leading hip replacement manufacturers.
RESULTS: According to administrative and literature data sources the reported crude primary THR rate varied between 50 and 130 procedures/100000 inhabitants in OECD countries in the 1990s. The crude overall hip implantation rate, summarising THR, partial hip replacement, and hip revision procedures, was reported to range from 60 to 200 procedures/100000 inhabitants in the late 1990s. Moreover, large national differences were seen in the relationship between total and partial hip replacement procedures.
CONCLUSION: The reported differences in hip replacement rates in OECD countries are substantial. They may be due to various causes, including different coding systems, country-specific differences in the healthcare system, in total expenditure on health per capita, in the population age structure, and in different indication criteria for THR.

Mesh:

Year:  2003        PMID: 12594106      PMCID: PMC1754456          DOI: 10.1136/ard.62.3.222

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  29 in total

1.  Measuring the success of joint replacement surgery.

Authors:  O D Williamson
Journal:  Med J Aust       Date:  1999-09-06       Impact factor: 7.738

2.  The Norwegian Joint Registry.

Authors:  L I Havelin
Journal:  Bull Hosp Jt Dis       Date:  1999

Review 3.  Advances in total hip arthroplasty.

Authors:  D Tate; T P Sculco
Journal:  Am J Orthop (Belle Mead NJ)       Date:  1998-04

Review 4.  Economics of osteoarthritis: a global perspective.

Authors:  L M March; C J Bachmeier
Journal:  Baillieres Clin Rheumatol       Date:  1997-11

5.  Prevalence of hip osteoarthritis in Iceland.

Authors:  T Ingvarsson; G Hägglund; L S Lohmander
Journal:  Ann Rheum Dis       Date:  1999-04       Impact factor: 19.103

6.  Incidence of total hip replacement for primary osteoarthrosis in Iceland 1982-1996.

Authors:  T Ingvarsson; G Hägglund; H Jónsson; L S Lohmander
Journal:  Acta Orthop Scand       Date:  1999-06

7.  Projecting the need for hip replacement over the next three decades: influence of changing demography and threshold for surgery.

Authors:  F Birrell; O Johnell; A Silman
Journal:  Ann Rheum Dis       Date:  1999-09       Impact factor: 19.103

8.  Total hip replacement rates are higher among Caucasians than Asians in Hawaii.

Authors:  C S Oishi; F T Hoaglund; L Gordon; P D Ross
Journal:  Clin Orthop Relat Res       Date:  1998-08       Impact factor: 4.176

9.  The economic cost of musculoskeletal disorders in Canada.

Authors:  P C Coyte; C V Asche; R Croxford; B Chan
Journal:  Arthritis Care Res       Date:  1998-10

10.  [Total hip replacement arthroplasty in the Netherlands].

Authors:  S Y Okhuijsen; W J Dhert; L M Faro; A J Schrijvers; A J Verbout
Journal:  Ned Tijdschr Geneeskd       Date:  1998-06-20
View more
  33 in total

1.  Do hip OA patients referred to orthopedic surgeons by general practitioners and rheumatologists differ?

Authors:  Maxime Samson; Jean-Francis Maillefert; Carine Roy; Christian Cadet; Philippe Ravaud
Journal:  Clin Rheumatol       Date:  2012-06-02       Impact factor: 2.980

Review 2.  [Wear particles: key to aseptic prosthetic loosening?].

Authors:  M Otto; J Kriegsmann; T Gehrke; S Bertz
Journal:  Pathologe       Date:  2006-11       Impact factor: 1.011

3.  Long-term trends in hip arthroplasty use and volume.

Authors:  Peter Cram; Xin Lu; John J Callaghan; Mary S Vaughan-Sarrazin; Xueya Cai; Yue Li
Journal:  J Arthroplasty       Date:  2011-07-12       Impact factor: 4.757

4.  Indications for total hip replacement: comparison of assessments of orthopaedic surgeons and referring physicians.

Authors:  K E Dreinhöfer; P Dieppe; T Stürmer; D Gröber-Grätz; M Flören; K-P Günther; W Puhl; H Brenner
Journal:  Ann Rheum Dis       Date:  2006-01-26       Impact factor: 19.103

5.  [Indications for joint replacement : Total hip arthroplasty].

Authors:  S Rahm; P O Zingg
Journal:  Z Rheumatol       Date:  2018-02       Impact factor: 1.372

6.  DICOM for implantations--overview and application.

Authors:  Thomas Treichel; Michael Gessat; Torsten Prietzel; Oliver Burgert
Journal:  J Digit Imaging       Date:  2012-06       Impact factor: 4.056

7.  Can We Afford Total Joint Replacements in Jamaica?

Authors:  K D Vaughan
Journal:  West Indian Med J       Date:  2014-07-14       Impact factor: 0.171

8.  [A new total knee arthroplasty with physiologically shaped surfaces. Part 2: First clinical results].

Authors:  K-H Frosch; H Nägerl; D Kubein-Meesenburg; J Buchholz; J Dörner; H Dathe; O Hellerer; C Dumont; K M Stürmer
Journal:  Unfallchirurg       Date:  2009-02       Impact factor: 1.000

9.  Relationship between body adiposity measures and risk of primary knee and hip replacement for osteoarthritis: a prospective cohort study.

Authors:  Yuanyuan Wang; Julie Anne Simpson; Anita E Wluka; Andrew J Teichtahl; Dallas R English; Graham G Giles; Stephen Graves; Flavia M Cicuttini
Journal:  Arthritis Res Ther       Date:  2009-03-05       Impact factor: 5.156

10.  Reduced rates of primary joint replacement for osteoarthritis in Italian and Greek migrants to Australia: the Melbourne Collaborative Cohort Study.

Authors:  Yuanyuan Wang; Julie A Simpson; Anita E Wluka; Donna M Urquhart; Dallas R English; Graham G Giles; Stephen Graves; Flavia M Cicuttini
Journal:  Arthritis Res Ther       Date:  2009-06-08       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.